Synthesis of Mercapturic Acid Derivatives of Putative Toxic Metabolites of Bromobenzen1e

Journal of Organic Chemistry

Volumn 55, Issue 9, 1990, Pages 2736-2742

  Hanzlik, Robert P ^a   Weller, Paul E ^a   Desai, Jayant ^a   Zheng, Jiang ^a   Hall, Larry R ^a   Slaughter, Donald E ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000402812     PISSN: 00223263     EISSN: 15206904     Source Type: Journal    
DOI: 10.1021/jo00296a034     Document Type: Article

References (36)

1. Financial support for this research was provided by NIH Grant GM-21784. L.R.H. is a NIH Predoctoral Trainee (GM-07775).
2. Mannervick, B. Adv. Emymol. Relat. Areas Mol. Biol. 1985, 57, 357–406.
3. Jakoby, W. B.; Stevens, J.; Duffell, M. W.; Weisiger, R. A. Rev. Biochem. Toxicol. 1984, 6, 97–115.
4. Bauman, E.; Preusse, C. Chem. Ber. 1879, 806-810.
5. Jaffe, M. Chem. Ber. 1879, 1092–1098.
6. Jongeneelen, F. J.; Dirven, H. A. A. M.; Leidekkers, C.-M.; Henderson, P. T.; Brouns, R. M. E.; Halm, K. J. Anal. Toxicol. 1987, 11, 100–104.
7. Hanzlik, R. P.; Weller, P. E.; Narasimhan, N.; Buben, J. A. Xenobiotic Metabolism and Disposition;Kato, R., Estabrook, R. W., Cayen, M. N., Eds.; Taylor & Francis: London, 1989; pp 367–374.
8. Monks, T. J.; Lau, S. S. Toxicology 1988, 52, 1–53.
9. Lau, S. S.; Monks, T. J. Life Sci. 1988, 42, 1259–1269.
10. Monks, T. J.; Lau, S. S.; Highet, R. J. Drug Metab. Dispos. 1984, 12, 432–437.
11. Monks, T. J.; Lau, S. S.; Highet, R. J.; Gillette, J. R. Drug Metab. Dispos. 1985, 13, 553–559.
12. Monks, T. J.; Lau, S. S.; Pohl, L. R.; Gillette, J. R. Drug Metab. Dispos. 1984, 12, 193–198, and references therein.
13. Zampaglione, N.; Jollow, D. J.; Mitchell, J. R.; Stripp, B.; Hamrick, M.; Gillette, J. R. J. Pharmacol. Exp. Ther. 1973, 187, 218–227.
14. Monks, T. J.; Pohl, L. R.; Gillette, J. R.; Hong, M.; Highet, R. J.; Ferretti, J. A.; Hinson, J. A. Chem.-Biol. Interact. 1982, 41, 203–216.
15. Lertratanangkoon, K.; Horning, E. C.; Horning, M. G. Drug Metab. Dispos. 1987, 15, 857–867.
16. Lau, S. S.; Zannoni, V. G. J. Pharmacol. Exp. Ther. 1981, 219, 563–572.
17. Hayden, P.; Schaeffer, V. H.; Larsen, G.; Stevens, J. L. Methods Enzymol. 1987, 143, 228–234.
18. van Bladeren, P. J.; Buys, W.; Breimer, D. D.; vander Gen, A. Eur. J. Med. Chem. 1980, 15, 495–597.
19. Bellamy, F. D.; Ou, K. Tetrahedron Lett. 1984, 25, 839–842.
20. Wilson, H. F.; Tarbell, D. S. J. Am. Chem. Soc. 1950, 72, 5200–5205.
21. Djerassi, C.; Gorman, M.; Markley, F. X.; Oldenburg, E. G. J. Am. Chem. Soc. 1955, 77, 568–571.
22. Burton, H.; David, S. B. J. Chem. Soc. 1952, 2193–2196.
23. Lau, P. T. S.; Kestner, M. J. Org. Chem. 1968, 33, 4426–4431.
24. Monks, T. J.; Highet, R. J.; Chu, P. S.; Lau, S. S. Mol. Pharmacol. 1988 34, 15–22.
25. Farlow, M. W. J. Biol. Chem. 1948, 176, 71–72.
26. Eiger, I. Z.; Greenstein, J. P. Arch. Biochem. 1948, 19, 467–473.
27. Behringer, H.; Fackler, E. Justus Liebigs Ann. Chem. 1949, 549, 73–78.
28. Stekol, J. A. J. Biol. Chem. 1936, 113, 279–288.
29. Such independent confirmation is frequently desirable if not actually necessary. For example, in a typical automated amino acid analysis procedure S-(p-bromophenyl)cysteine coelutes with histidine. Conversion of the former to the thioanisoles eliminates this problem in a useful way.
30. Doyle, M. P.; Siegfried, B.; Dellaria, J. F., Jr. J. Org. Chem. 1977, 42, 2426–2430.
31. Sihlbom, L. Acta Chem. Scand. 1953, 7, 1197–1206.
32. Suthers, B. R.; Riggins, P. H.; Pearson, D. E. J. Org. Chem. 1962, 27, 447–451.
33. The purpose of adding the diazonium reagent to the hot xanthate is to avoid accumulation of ArN=NSC(S)OEt intermediates that are potentially explosive. See: Organic Syntheses; Wiley: New York, 1955; Collect. Vol. III, p 809.
34. Rinehart, K. L., Jr.; McMillan, M. W.; Witty, T. R.; Tipton, C. D.; Shield, L. S. Bioorg. Chem. 1977, 6, 353–369.
35. Balough, V.; Fetizon, M.; Golf, M. J. Org. Chem. 1971, 36, 1339–1341.
36. Underwood, H. W.; Walsh, W. L. J. Am. Chem. Soc. 1936, 58, 646–647.